2[3]Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. London: Oxford University Press, 1996:26
3[5]Spilker B. Quality of life and pharmacoeconomics in clinical trails. Second edition. Philadephia: Lippincott-Raven Publish ers, 1996:253
同被引文献4
1Ambrose PG, Rieherson MA. Stanton MD. et al. Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia. Infections Disease in Clinical Practice.1999,8(5) :215.
2Klein NC, Gumha BA, Third-generation cephalosporins. Medical Clinics of North America, 1995,79 : 705.
3Brown R, Once daily ceftriaxone in the treatment of lower respiratory tract infections. Chemotherapy, 1991,37 : 11.
